The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - ImmunoGen
Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients (pts) with platinum-resistant ovarian cancer: Final findings from the FORWARD II study.
 
David M. O'Malley
Honoraria - Abbvie; Ambry Genetics; AstraZeneca; BioMedical Insights; Clovis Oncology; Genentech/Roche; GOG Foundation; Immunogen; Janssen Oncology; Marker Therapeutics; Myriad Genetics; Novocure; OncLive; OncoQuest; Prime Oncology; Targeted Oncology; Tesaro; Translational Genomics Research Institute
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Clovis Oncology; Genentech/Roche; GOG Foundation; Immunogen; Janssen Oncology; Myriad Genetics; Novocure; OncoQuest; Tesaro; Translational Genomics Research Institute
Research Funding - Agenus (Inst); Ajinomoto (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Clovis Oncology (Inst); EMD Serono (Inst); Ergomed (Inst); Genentech/Roche (Inst); Genmab (Inst); Immunogen (Inst); Immunogen (Inst); Janssen Research & Development (Inst); PharmaMar (Inst); Regeneron (Inst); Seagen (Inst); Stem CentRx (Inst); Tesaro (Inst); TRACON Pharma (Inst); VentiRx (Inst)
 
Ursula A. Matulonis
Consulting or Advisory Role - 2X Oncology; Fujifilm; Geneos; Immunogen; Merck; Mersana; Myriad Genetics
Research Funding - Merck; Novartis; Syndax; Tesaro
 
Michael J. Birrer
Consulting or Advisory Role - Acceleron Pharma; AstraZeneca; Clovis Oncology; Immunogen; Immunogen; Merrimack; Oxigene; Roche/Genentech; Sanofi; Tesaro; Threshold Pharmaceuticals
 
Cesar Martin Castro
Consulting or Advisory Role - Advance Medical; InfiniteMD; N-of-One
Research Funding - ImmunoGen (Inst)
Patents, Royalties, Other Intellectual Property - Exosome Diagnostics
 
Ignace Vergote
Consulting or Advisory Role - Advaxis (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Eisai (Inst); Genmab (Inst); Immunogen (Inst); Millennium (Inst); MSD Belgium (Inst); Oncoinvent (Inst); PharmaMar (Inst); Roche (Inst); Roche (Inst); Sotio (Inst); Tesaro (Inst)
Research Funding - Amgen (Inst); Genmab (Inst); Oncoinvent (Inst); Roche (Inst); Stichting tegen kanker (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Genmab; PharmaMar; Roche; Takeda; Tesaro
 
Lainie P. Martin
Consulting or Advisory Role - Immunogen; Tesaro
Research Funding - Abbvie (Inst); Clovis Oncology (Inst); Immunogen (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Tesaro (Inst); TetraLogic Pharmaceuticals (Inst); Teva (Inst)
Travel, Accommodations, Expenses - Immunogen; Tesaro
 
Gina Mantia-Smaldone
Consulting or Advisory Role - Tesaro
 
Lucy Gilbert
Honoraria - AstraZeneca; Pfizer; Roche
Research Funding - Aeterna Zentaris (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); ImmunoGen (Inst); Pfizer (Inst); Tesaro (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer
 
Antonio González-Martín
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; MSD; Pfizer; PharmaMar; Roche; Tesaro
Speakers' Bureau - AstraZeneca; PharmaMar; Roche; Tesaro
Research Funding - Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche; Tesaro
 
Raquel Bratos
No Relationships to Disclose
 
Brooke Esteves
No Relationships to Disclose
 
Karim S. Malek
Employment - ImmunoGen
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; Aravive; AstraZeneca; Clovis Oncology; Genentech/Roche; Immunogen; Janssen Oncology; Merck; OncoMed; Pfizer/EMD Serono; Samumed; TESARO; VBL Therapeutics
Speakers' Bureau - AstraZeneca
Research Funding - Abbvie/Stemcentrx (Inst); Advaxis (Inst); Agenus (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Forty Seven (Inst); Genentech (Inst); Immunogen (Inst); Lilly (Inst); Lilly Foundation (Inst); Merck (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Novogen (Inst); PTC Therapeutics (Inst); Regeneron (Inst); Stem CentRx (Inst); Takeda (Inst); Tesaro (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
Other Relationship - AstraZeneca